MiMedx Group, Inc. provides revenue guidance for the financial year 2022. For the period, the company expects annual revenue growth of 11% to 14% in the Company's continuing portfolio of products.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.5 USD | +2.60% | +20.10% | -14.48% |
04-30 | Transcript : MiMedx Group, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
04-30 | Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 Revenue $84.7M, vs. Street Est of $79.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.48% | 1.11B | |
-19.12% | 130M | |
-3.21% | 70.83M | |
+6.78% | 60.91M | |
-0.60% | 52.02M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- MiMedx Group, Inc. Provides Revenue Guidance for the Financial Year 2022